CA
BMRN icon

Continuum Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Continuum Advisory’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.91M Buy
104,536
+3,116
+3% +$182K 0.57% 36
2025
Q4 		$6.03M Buy
+101,420
New +$5.52M 0.6% 41
2025
Q2 		– Sell
-11
Closed -$778 – 548
2025
Q1 		$778 Sell
11
-6
-35% -$404 ﹤0.01% 1542
2024
Q4 		$1.12K Sell
17
-10
-37% -$670 ﹤0.01% 1589
2024
Q3 		$1.77K Sell
27
-8
-23% -$669 ﹤0.01% 1480
2024
Q2 		$2.88K Hold
35
– – ﹤0.01% 1211
2024
Q1 		$2.86K Buy
+35
New +$3.13K ﹤0.01% 1199

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return